Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
Clinical trial NCT01656980 · UNKNOWN
Trial details
- NCT number
- NCT01656980
- Sponsor
- Shandong Lanjin Pharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-08-01
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.